Clinical trial Recruiting at 3 sites Interventional Ages 21 and up

Home-based vs. in-clinic upper extremity rehabilitation after stroke

Official title: Efficacy of Tele-CPASS, a Telerehabilitation Intervention Using Critical Periods After Stroke Study (CPASS) Compared to In-person CPASS for Upper Extremity Motor Recovery

Run by University of Texas, El Paso · NCT07661849 · Data updated 2026-11-12

This study tests whether a 20-hour home telerehabilitation program (tele-CPASS) works as well as the same in-clinic CPASS therapy for improving arm and hand function after stroke.

Quick facts

Study typeInterventional
Ages21 Years and up
SexAll
Enrollment42 (estimated)
SponsorUniversity of Texas, El Paso
Academic / other
Locations3 sites (El Paso, Texas and 2 other locations)
StatusRecruiting
StartedSeptember 1, 2025
Main results expectedAugust 31, 2028
Study endsAugust 31, 2029
Registry record updatedJune 22, 2026
Trial IDNCT07661849 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 21 and older with a recent stroke (within 40 days) and persistent upper-extremity impairment who can participate in home or in-clinic therapy and attend follow-ups.

Probably not a fit

Patients without sufficient cognitive or motor ability to participate or who cannot access either in-home or in-clinic therapy may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, parallel-group trial compares tele-CPASS delivered at home to in-person CPASS therapy for adults with recent stroke and persistent upper-extremity impairment. Both groups receive the same 20 hours of task-specific therapy focused on meaningful daily activities, with assessments before, immediately after, and at 6 and 12 months to gauge motor recovery, real-world arm use, and participation. The study builds on prior CPASS work showing benefits of intensive upper-extremity training and explores whether a telerehabilitation format can maintain efficacy while improving access. Eligible participants are adults 21 or older with a recent ischemic or hemorrhagic stroke within 40 days, measurable upper-extremity impairment, and adequate cognitive function to participate. The trial will be conducted at multiple sites in El Paso, TX, led by the University of Texas, El Paso, with collaborators at Texas Tech University Health Sciences Center El Paso and The Catholic University of America.

Why it matters

Potential benefit: If successful, tele-CPASS could provide similar improvements in arm function and daily use while offering greater accessibility for stroke survivors.

How similar studies have gone: Previous CPASS trials showed meaningful motor gains with 20 hours of intensive therapy, but telehealth versions have not been rigorously compared head-to-head with in-person CPASS.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 21 years or older
* Neuroimaging-confirmed stroke within 40 days prior to enrollment
* Persistent hemiparesis resulting in impaired upper extremity function, defined by a score of 0 to 3 on the NIH Stroke Scale motor arm item
* Able to participate in all study-related activities, including 1-year follow-up
* Short Blessed Memory Orientation and Concentration Scale score less than 8
* Able to follow 2-step commands
* Montreal Cognitive Assessment (MoCA) score greater than 25
* No upper extremity injury or condition that limited upper extremity use prior to the stroke

Exclusion Criteria:

* Inability to provide informed consent
* Persistent disabling neurologic condition, such as multiple sclerosis, Parkinsonism, amyotrophic lateral sclerosis, or dementia requiring medication
* Clinically significant fluctuations in mental status within 72 hours prior to randomization
* Active psychosis, psychosis within the prior 2 years, active substance abuse, or prior substance abuse
* Dense sensory loss, defined by a score of 3 or 4 on the NIH Stroke Scale sensory item
* Ataxia out of proportion to weakness in the affected arm, defined by a score greater than 1 on the NIH Stroke Scale ataxia item
* Not expected to survive 12 months because of other illnesses
* Pregnancy
* Severe aphasia
* Receipt of botulinum toxin or expectation of receiving botulinum toxin during the study period

Where it's running

  • Rehabilitation Sciences Complex, University of Texas at El Paso, 3333 N Mesa St, El Paso, TX 79902
    El Paso, Texas, United States
    Recruiting
  • Texas Tech University Health Sciences Center El Paso - Neurology Clinic
    El Paso, Texas, United States
    Recruiting
  • University Medical Center of El Paso - Rehabilitation Services
    El Paso, Texas, United States
    Recruiting

Study contacts

  • Principal investigator: Dr. Shashwati Geed, PT, PhD — Department of Physical Therapy and Movement Sciences, University of Texas at El Paso
  • Study coordinator: Dr. Shashwati Geed, PT, PhD
  • Email: sgeed@utep.edu
  • Phone: 915-747-7289

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.